Antonio Sergio Petrilli, MD, PhD,1 Algemir Lunardi Brunetto, MD, PhD,2 Monica dos Santos Cypriano, MD,1 Alexandre Archanjo Ferraro, MD, PhD,3 Carla Renata Pacheco Donato Macedo, MD,1 Andreza Almeida Senerchia, MD,1 Maria Teresa Almeida, MD,4 Cecilia Maria da Costa, MD,5 Daniel Lustosa, MD,6 Maria Luiza Borsato, MD,7 Luiz Mario Calheiros, MD,8 Jose Henrique Silva Barreto, MD,9 Sidnei Epelman, MD,10 Eny Carvalho, MD,11 Maria Teresa Seixas Alves, MD, PhD,1 Marcelo de Toledo Petrilli, MD,1 Valter Penna, MD, PhD,12 Pedro Pericles, MD,7 Olavo Pires de Camargo, MD, PhD,3 and Reynaldo Jesus Garcia-Filho, MD, PhD,1 on behalf of the Brazilian Osteosarcoma Treatment Group.


Abstract

Purpose: Little information is available regarding the tumor features, prognostic factors, and treatment results in children and adolescents and young adults (AYAs) with osteosarcoma diagnosed in developing countries. We reviewed the results of three observational cohorts of osteosarcoma patients treated in an emerging country.

Methods: A total of 604 patients below the age of 30 years with high-grade osteosarcoma were prospectively enrolled in the Brazilian Osteosarcoma Treatment Group (BOTG) studies III, IV, and V. Gender, age, time from onset of symptoms to diagnosis, primary tumor site, presence or absence of metastases at diagnosis, tumor size, type of surgery (limb-sparing or amputation), treatment protocol, and histological response were correlated with survival.

Results: The estimated 5-year overall survival and event-free survival (EFS) rates for the 553 eligible patients were 49% and 39% respectively; of the 390 non-metastatic patients included in the total, overall- and event-free survival were 59% and 48% respectively. Metastases at diagnosis, primary tumor site, type of surgery, and histological response were significant predictors of overall survival and EFS in univariate and multivariate analysis, whereas tumor size and treatment protocol lost prognostic significance in multivariate analysis.

Conclusion: We report on the outcome of three consecutive studies for the treatment of osteosarcoma carried out in Brazil over 15 years. Although the survival rates presented are below those reported in current literature, it represents the result of a favorable experience gathered from the national collaborative work.

Keywords: osteosarcoma, survival, prognostic factors, emerging country, cooperative group


pdf-icon1